Citigroup’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-775
Closed -$11.6K 5229
2022
Q4
$11.6K Sell
775
-4,145
-84% -$62K ﹤0.01% 4086
2022
Q3
$40K Sell
4,920
-400
-8% -$3.25K ﹤0.01% 3781
2022
Q2
$35K Buy
5,320
+3,860
+264% +$25.4K ﹤0.01% 4021
2022
Q1
$8K Buy
+1,460
New +$8K ﹤0.01% 4867
2021
Q3
Sell
-24
Closed 5761
2021
Q2
$0 Sell
24
-1,422
-98% ﹤0.01% 5849
2021
Q1
$11K Sell
1,446
-2,666
-65% -$20.3K ﹤0.01% 4948
2020
Q4
$24K Buy
4,112
+3,044
+285% +$17.8K ﹤0.01% 4542
2020
Q3
$6K Sell
1,068
-718
-40% -$4.03K ﹤0.01% 4613
2020
Q2
$9K Buy
1,786
+1,766
+8,830% +$8.9K ﹤0.01% 4699
2020
Q1
$0 Sell
20
-1,775
-99% ﹤0.01% 5337
2019
Q4
$12K Sell
1,795
-1,240
-41% -$8.29K ﹤0.01% 4679
2019
Q3
$25K Sell
3,035
-1,016
-25% -$8.37K ﹤0.01% 4160
2019
Q2
$27K Buy
4,051
+1,229
+44% +$8.19K ﹤0.01% 4459
2019
Q1
$23K Sell
2,822
-1,184
-30% -$9.65K ﹤0.01% 4470
2018
Q4
$64K Buy
4,006
+109
+3% +$1.74K ﹤0.01% 3760
2018
Q3
$128K Buy
3,897
+1,676
+75% +$55.1K ﹤0.01% 3427
2018
Q2
$50K Buy
2,221
+2,037
+1,107% +$45.9K ﹤0.01% 3873
2018
Q1
$5K Sell
184
-84
-31% -$2.28K ﹤0.01% 4636
2017
Q4
$7K Buy
268
+1
+0.4% +$26 ﹤0.01% 4604
2017
Q3
$10K Buy
267
+176
+193% +$6.59K ﹤0.01% 4226
2017
Q2
$2K Buy
+91
New +$2K ﹤0.01% 4626
2016
Q2
Sell
-29
Closed 5451
2016
Q1
$0 Sell
29
-6
-17% ﹤0.01% 5750
2015
Q4
$0 Buy
+35
New ﹤0.01% 5804
2015
Q3
Sell
-36
Closed -$1K 5737
2015
Q2
$1K Buy
+36
New +$1K ﹤0.01% 5422
2015
Q1
Sell
-100
Closed -$1K 5769
2014
Q4
$1K Buy
100
+67
+203% +$670 ﹤0.01% 5380
2014
Q3
$0 Sell
33
-123
-79% ﹤0.01% 5689
2014
Q2
$3K Sell
156
-3,781
-96% -$72.7K ﹤0.01% 5037
2014
Q1
$59K Buy
3,937
+1,907
+94% +$28.6K ﹤0.01% 3874
2013
Q4
$37K Buy
2,030
+48
+2% +$875 ﹤0.01% 4300
2013
Q3
$41K Sell
1,982
-312
-14% -$6.45K ﹤0.01% 3812
2013
Q2
$58K Buy
+2,294
New +$58K ﹤0.01% 3679